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Abstract
The extent to which bone marrow (BM) contributes to physiological cell renewal is still controversial. Using the marker human placental
alkaline phosphatase (ALPP) which can readily be detected in paraffin and plastic sections by histochemistry or immunohistochemistry,
and in ultrathin sections by electron microscopy after pre-embedding staining, we examined the role of endogenous BM in physiological
cell renewal by analysing tissues from lethally irradiated wild-type inbred Fischer 344 (F344) rats transplanted (BMT) with unfractionated
BM from ALPP-transgenic F344 rats ubiquitously expressing the marker. Histochemical, immunohistochemical and immunoelectron
microscopic analysis showed that the proportion of ALPP
 capillary endothelial cells (EC) profoundly increased from 1 until 6 months
after BMT in all organs except brain and adrenal medulla. In contrast, pericytes and EC in large blood vessels were ALPP
–. Epithelial cells
in kidney, liver, pancreas, intestine and brain were recipient-derived at all time-points. Similarly, osteoblasts, chondrocytes, striated muscle
and smooth muscle cells were exclusively of recipient origin. The lack of mesenchymal BM-derived cells in peripheral tissues prompted
us to examine whether BMT resulted in engraftment of mesenchymal precursors. Four weeks after BMT, all haematopoietic BM cells were
of donor origin by flow cytometric analysis, whereas isolation of BM mesenchymal stem cells (MSC) failed to show engraftment of donor
MSC. In conclusion, our data show that BM is an important source of physiological renewal of EC in adult rats, but raise doubt whether
reconstituted irradiated rats are an apt model for BM-derived regeneration of mesenchymal cells in peripheral tissues.
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Introduction
Insights into the mechanisms of physiological cell renewal in adult
organs are of fundamental importance for medicine and biology.
Earlier reports indicate that bone marrow (BM)-derived precursor
cells play a role in cell renewal and repair in many adult organs.
For example, female patients receiving sex-mismatched bone 
marrow transplantation (BMT) show integration of male donor
cells into brain as neurons, into heart as cardiomyocytes, into 
kidney as tubular epithelial cells, into liver as hepatocytes and
cholangiocytes, and into lung as epithelial and endothelial cells
(EC; reviewed in [1]). Similarly, irradiated mice reconstituted with
green fluorescent protein (GFP) or lacZ-labelled BM show partici-
pation of BM-derived cells in the renewal of endothelial [2], epithelial
[3, 4] and mesenchymal [5] cells in various organs. In addition, it
was reported that mobilization of endogenous bone marrow cells
(BMC) after acute myocardial infarction contributes to regeneration
of cardiac muscle [6]. Collectively, these findings have lead to the
concept that circulating BM-derived precursor cells participate in
physiological cell renewal and repair in many adult organs.
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Furthermore, it was suggested that haematopoietic stem cells may
trans-differentiate into epithelial and also mesenchymal lineage
cells [4, 7–9]. However, these interpretations have been ques-
tioned on the ground of data indicating methodological problems
involved in some of these studies [10–12]. Therefore, the role of
BM in physiological cell renewal is still a matter of controversy.
Recent work from our laboratory has shown that human pla-
cental alkaline phosphatase (ALPP) is a highly suitable marker
enzyme for histological tracking of genetically labelled cells in all
tissues, including hard tissues. In contrast to endogenous heat-
labile alkaline phosphatases, ALPP is heat-stable and therefore its
enzymatic activity is retained after heat pre-treatment of paraffin
and methylmethacrylate sections [13]. As a consequence, ALPP-
labelled cells are easily detectable histologically in the total absence
of background staining. To examine the role of BM in physiological
cell renewal in various organs, we lethally irradiated 3-month-old
wild-type (wt) Fischer 344 (F344) rats, and reconstituted them with
unfractionated BM from R26-ALPP transgenic (ALPP-tg) sex-
matched F344 donors. R26-ALPP-tg rats express ALPP in a ubiq-
uitous and stable fashion under the R26 promoter, which is a 0.8
kb fragment of the ROSA geo 26 promoter sequence [13–15].
ALPP is mainly expressed in the cell membrane, irrespective of the
cell type analysed [13, 16], and is developmentally neutral in trans-
genic rats and mice [14]. Graft-versus-host reactions can be ruled
out a priori in this co-isogeneic BMT model, because F344 rats are
an inbred strain. In this sequential study, the reconstituted rats
were followed over a 6-month period after BMT.
Materials and Methods
Animals
All experimental procedures were conducted in compliance with prevailing
animal welfare regulations. Hemizygous male or female R26-F344 ALPP-tg
rats were mated with wt F344 rats, and the resulting wt and hemizygous tg
offspring were genotyped as described [14]. Rats were housed in pairs at
24C and a 12 hrs/12 hrs light/dark cycle with free access to tap water and
commercial rat diets (Altromin, Lage, and Ssniff, Soest, Germany).
Lethal irradiation and bone marrow transplantation
Three-month-old wt F344 rats were lethally irradiated with a single dose of
8.5 Gy using a cobalt-60 irradiator (Eldorado, Atomic Energy of Canada,
Ottawa, Canada), or with a single dose of 8.0 or 9.0 Gy using a linear accel-
erator (Siemens Primus, Munich, Germany). Four hours after irradiation,
rats were intravenously injected with 4  10
6 unfractionated BMC isolated
from sex-matched ALPP-tg co-isogeneic F344 donors. To rule out unsuc-
cessful engraftment, injection of freshly prepared tg BMC was repeated 
24 hrs after irradiation. For the time course study, groups of four to six rats
each were killed 1, 2, 4 and 6 months after BMT through exsanguination
from the abdominal aorta under ketamine/xylazine anaesthesia. For mes-
enchymal stem cells (MSC) isolation experiments, animals were killed 
4 weeks after BMT.
Flow cytometric detection of ALPP
To determine the degree of chimerism in haematopoietic BMC after BMT,
unfractionated BMC were harvested and analysed by fluorescence-activated
cell sorting (FACS) as described [16], using a monoclonal anti-ALPP antibody
(Chemicon, Temecula, CA, USA) and rat-adsorbed, fluorescein isothiocyanate
(FITC)-labelled goat antimouse IgG antibody (Sigma-Aldrich, Deisenhofen,
Germany). The standard curve for determination of the degree of chimerism
was obtained by mixing wt BMC with BMC from ALPP-tg rats at various
known ratios.
ALPP histology and detection
Tissue samples of heart, lung, liver, kidney, lymph nodes, spleen, brain,
skeletal muscle, skin and bones were fixed in 40% ethanol at 4C for 
48 hrs, dehydrated and embedded in paraffin or modified methylmethacry-
late [15]. Five-micrometre-thick sections were mounted on slides pre-treated
with 3-aminopropyltriethoxy-silane (Sigma-Aldrich). Deparaffinated or
deplasticized sections were rehydrated and heated at 65C for 30 min. in
deionized water to block endogenous ALPP activity. Cells expressing ALPP
were histochemically stained by incubation with an alkaline phosphatase
(AP) substrate (0.1 M Tris-HCl, pH 9.5, 0.1 M NaCl, 5 mM MgCl2, containing
0.175 mg/ml of the substrate 5-bromo-4-chloro-3-indolyl phosphate [BCIP,
Sigma] and 0.45 mg/ml nitrotetrazolium blue chloride [NBT, Sigma]) at room
temperature (RT) overnight. Subsequently, sections were counterstained
with nuclear fast red (Sigma-Aldrich), dehydrated, and cover-slipped using
Vectamount (Vector, Burlingame, CA, USA).
The combination of histochemistry for ALPP detection and immunohis-
tochemistry (IHC) for the detection of various antigens was performed as
follows: In a first step, histochemical detection of ALPP
 cells was
performed after heat inactivation of endogenous ALPP as described above
by incubating the slides for 4 hrs with the AP substrate Vector Blue (Vector)
at RT in the dark. For vimentin staining, slides were pre-treated in the
microwave for 2  3 min. in citrate buffer pH 6. After quenching of endoge-
nous peroxidase activity by using 3% H2O2 in phosphate-buffered saline
(PBS) for 15 min., slides were incubated with 20% horse, goat or rabbit
serum (Vector) for 20 min. Thereafter, slides were incubated with mouse
anti-human smooth muscle actin (SMA; Dako, Glostrup, Denmark) diluted
1:200, mouse anti-vimentin (Dako) diluted 1:200, goat anti-rat CD34 (R&D,
Wiesbaden-Nordenstadt, Germany) diluted 1:50, or mouse anti-rat CD68
(Serotec, Harwell, UK) diluted 1:100 in PBS containing 5% of the appropri-
ate serum at 4C overnight. For double staining of pancreatic samples, slides
were incubated with guinea pig anti-porcine insulin (Dako) diluted 1:2000,
rabbit anti-human pancreatic polypeptide (Dako) diluted 1:700 or rabbit anti-
human somatostatin (Dako) diluted 1:700 for 2 hrs in PBS containing 5%
rabbit respective goat serum at RT. Bound antibody was detected by incuba-
tion for 0.5–1 hrs at RT with biotinylated rat-adsorbed horse antimouse
antibody 1:50 (Vector), horse anti-goat antibody 1:50 (Vector), rabbit anti-
guinea pig IgG 1:100 (Dako) or biotinylated goat anti-rabbit antibody 1:200
(Vector), as appropriate. Staining was accomplished by applying avidin-
biotin complex (ABC)-peroxidase (Vector) for 30 min., followed by incuba-
tion with the peroxidase substrate VIP (Vector) for 0.5 to 2 min., resulting in
purple staining of positive cells. For vimentin and SMA co-staining, we first
performed SMA-IHC, visualized by ABC-AP-complex (Vector) and Vector
Blue using levamisole (Vector) for inhibition of endogenous APs and ALPP
enzyme activity. Subsequently, after blocking with avidin/biotin (Vector),
vimentin-IHC was performed as described, using ABC-peroxidase complex
and VIP as substrate. For the staining of EC with the tomato lectin2234 © 2011 The Authors
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Lycopersicon esculentum, slides were incubated with the biotinylated lectin
[Vector; 1:200 in hydroxethyl-piperazine-ethanesulfonic acid (HEPES) buffer
for 2 hrs at RT] after histochemical ALPP staining and blocking of endoge-
nous peroxidase. Visualization was performed with the ABC-peroxidase kit
as described above. No counterstaining was carried out, and slides were
cover-slipped using aqueous gelatine (Merck, Darmstadt, Germany).
ALPP immuno-electron microscopic analysis
For transmission electron microscopy, tissue samples from heart and kid-
ney were fixed in 4% paraformaldehyde for 24 hrs at 4C. Samples were
frozen in liquid nitrogen with Optimal Cutting Temperature (OCT) com-
pound (Sakura Finetek, Zoeterwoude, Netherlands), and 45-m-thick sec-
tions were cut using a cryotome (Leica 1800 CM, Bensheim, Germany).
Sections were post-fixed in 4% paraformaldehyde for 1 hrs and rinsed in
0.1 M phosphate buffer 3  10 min. Peroxidase activity was inhibited by
3% H2O2 in PBS for 30 min. and non-specific binding was minimized by
incubation with 3% normal goat serum containing 1% bovine serum albu-
min (BSA) for 60 min. at RT. Incubation with anti-ALPP (Genetex, Irvine,
CA, USA), diluted 1:50 in blocking solution, was carried out at 4C
overnight. As a control, in order to visualize EC in general, sections were
stained with anti-human von Willebrand factor (vWF, Dako), 1:600, or
CD34 1:50. For negative controls, the primary antibody was omitted.
Peroxidase-labelled rabbit PowerVision™ (ImmunoVision Technologies,
Burlingame, CA, USA) secondary system was employed for antibody
detection with subsequent DAB staining (Sigma-Aldrich). The reaction was
stopped by rinsing with PBS 3  10 min. Sections were placed in 0.1 M
phosphate buffer and kept at 4C before embedding. Post-fixation was per-
formed in 1% osmium tetroxide for 2 hrs at RT followed by dehydration
and incubation in propylene oxide, propylene oxide-epon and subsequent
embedding in pure epon 812. Thin sections were stained with lead citrate,
and were investigated under a transmission electron microscope (Zeiss EM
900; Zeiss, Oberkochen, Germany).
Quantification of endothelial cells in myocardium
The percentage of ALPP
 capillary EC was quantified in ALPP-stained
sections in seven optical fields per animal at 400 magnification, evenly
distributed over the left ventricular (five fields) and septal (two fields)
myocardium. Using a one-phase exponential model, nonlinear 
regression analyses were performed with Prism 5.03 (GraphPad Software,
Inc., San Diego, CA, USA).
MSC isolation, cultivation and staining
MSC were isolated from long bones of wt, ALPP-tg, and BMT rats, using
an isolation protocol described elsewhere [17]. After 24 hrs, the non-
adherent cell fraction was removed by washing twice with D-PBS
(Invitrogen, Paisley, UK). After the primary culture had reached confluence,
cells were washed twice with D-PBS, and subsequently treated with 0.05%
trypsin / 1 mM ethylenediaminetetraacetic acid (EDTA) (Invitrogen) for 
5 min. at 37C. Cells were harvested, washed once in MEM and further
expanded. For histochemical staining of cultivated MSC, MSC were seeded at
100,000/cm
2 in culture flasks or at 1300/cm
2 in 12-well plates and cultivated
for 3 to 7 days until confluency. After fixation with ice-cold acetone-
methanol (30/70), plates were washed several times with PBS and endoge-
nous APs were inactivated at 65C for 30 min. Histochemical staining for
heat-stable ALPP was performed with the AP substrate BCIP/NBT as
described above. Each cell preparation was stained at least in triplicates,
MSC isolated from ALPP-tg and wt donors served as controls.
DNA isolation and Southern blot analysis 
of cultivated MSC
For DNA isolation, cells were covered with 100 mM Tris-HCl, pH 8.5, 5 mM
EDTA, 0.2% SDS, 200 mM NaCl, 100 g/ml proteinase K and incubated at
55C for 2 hrs. Before phenol/chloroform/iso-amylalcohol (PCI) extraction,
debris was removed by centrifugation at 10,000  g. PCI extraction was
repeated at least twice in order to yield a clear aqueous phase and inter-
phase. Before alcohol precipitation, the solution was extracted once with
chloroform/iso-amylalcohol. Large amounts of precipitated DNA were
removed using a pipette tip, otherwise the precipitate was centrifuged and
the pellet washed in 70% ethanol. The moist pellet was dissolved in 10 mM
Tris-HCl pH 7.5, 1 mM EDTA by incubation overnight at 55C and the solu-
tion was stored at 4C. For Southern analysis, 10 g of genomic DNA were
restricted with 20 units of endonuclease EcoRI (NEB Biolabs, Ipswitch,
MA, USA) together with 1 g/l RNAseA (Fermentas, St. Leon-Rot,
Germany) in an appropriate buffer at 37C overnight. The DNA was then
separated by 1% Tris-acetate-EDTA (TAE)/agarose gel electrophoresis, and
the ethidium bromide-stained gel was photo documented under UV irradi-
ation. Before transfer to Biodyne
® Plus Nylon membrane (Pall Corporation,
Dreieich, Germany) in 10 SSPE, the gel was immersed for 15 min. in
0.25 N HCl, followed by 30 min. 0.4 N NaOH/0.6 M NaCl, and a 30 min.
incubation in 1.5 M NaCl/0.5 M Tris-HCl, pH 7.5. The transferred DNA was
immobilized onto the membrane by UV irradiation (0.12 J/cm
2;
Stratalinker, Stratgene, La Jolla, CA, USA). The dried membrane was pre-
hybridized for 2 hrs at 65C with 5 SSC, 5 Denhardt, 1% SDS. After
replacement of buffer, a 
33P-labelled probe specific to the transgene insert
was hybridized for 18 hrs at 65C. The membrane was washed (0.2
SSPE, 0.1% SDS at 65C) and exposed for 72 hrs to a Fuji imaging plate
(MS30170095), which was subsequently scanned by a Fuji Bas 1800-II
phosphoimager (Fuji, Tokyo, Japan).
Results
The current study employed two different radiation sources,
namely a cobalt-60 source and a linear accelerator. We reported
previously that irradiation of F344 rats at a single dose of 8.5 Gy
using a cobalt-60 irradiator followed by transplantation with
ALPP-tg BM results in full replacement of the haematopoietic
compartment as documented by FACS analysis of BMC [16]. In
dose–response experiments with the linear accelerator, we found
in two independent experiments that a single irradiation dose of 
9 Gy was necessary to obtain wt F344 rats in which host BMC
were fully replaced by ALPP-tg BMC (Fig. 1H, I).
A prerequisite for our study was that ALPP is ubiquitously
expressed in the target tissues to be analysed. Our earlier work
had shown that ALPP is strongly expressed in haematopoietic
cells, lung, spleen, lymph nodes and in BM stromal cells such as
osteoblasts, osteocytes and chondrocytes in R26-ALPP-tg ratsJ. Cell. Mol. Med. Vol 15, No 10, 2011
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Fig. 1 Expression of the marker enzyme ALPP in tissues of ALPP-transgenic (ALPP-tg) F344 rats and chimerism after reconstitution of irradiated wt rats
with ALPP-tg BM. (A)–(G)  Histochemical staining showed strong and ubiquitous expression of ALPP in cells of epithelial, endothelial and mesenchymal
origin in kidney (A), gut (B), liver (C), heart muscle (D), arteries (E), lung (F), as well as exocrine and endocrine pancreas (G) in ALPP-tg rats. The 5-m-
thick paraffin sections shown in (A)–(G) were stained for ALPP enzyme activity (BCIP/NBT, purple) overnight at RT after heat pre-treatment, and were
counterstained with nuclear fast red. Bars represent 50 m. (H)–(I) FACS analysis of BMC isolated from wt rats lethally irradiated with a linear accelera-
tor, using a single dose of 8 or 9 Gy, and reconstituted with unfractionated BM harvested from ALPP-tg donors. Irradiation with 9 Gy resulted in high
ALPP chimerism (96.9  6.4%), whereas chimerism was much lower using a single dose of 8 Gy (53.6  22.7%). Chimerism was determined on the
basis of a standard curve. Representative single parameter fluorescence histogram (I) shows hPLAP expression (marker M2) on nearly all BMC in recon-
stituted wt rats after irradiation with 9 Gy (green line), similar to BMC from hPLAP-tg rats (violet area). Irradiation with 8 Gy (black line) resulted in lower
degree of chimerism. The red area depicts ALPP
– (marker M1) BMC from wt control rats.2236 © 2011 The Authors
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[13, 16]. In the current study, we examined the expression of ALPP
in kidney, gut, liver, heart, arteries, lung and pancreas of ALPP-tg
rats. We found strong expression of the marker enzyme in endothe-
lial, epithelial and mesenchymal cells in all these tissues (Fig. 1A–G).
When we started to examine the occurrence of ALPP
 cells in
various organs of irradiated wt rats reconstituted with unfractionated
BM from ALPP-tg donors, the most striking finding was a high
number of ALPP
 endothelial-like cells in capillaries of kidney
(Fig. 2A), lung (data not shown), pancreas (Fig. 2B), liver (Fig. 2C)
and heart (Fig. 2D–F). In contrast, ALPP labelling of EC was absent
in the medulla of adrenal glands (data not shown), in brain (data
not shown) and in large blood vessels such as aorta (Fig. 2G),
arteries, or veins (not shown). To explore further the nature of the
ALPP-labelled endothelial-like cells, we performed co-staining
experiments. Co-staining of ALPP enzyme activity with tomato
lectin (Fig. 2H) or monoclonal mouse anti-CD34 (data not shown)
suggested that the majority of the ALPP
, endothelial-like cells
were indeed EC in the heart. However, in kidneys we observed
many ALPP
 endothelial-like cells which stained negative for
tomato lectin and CD34. In addition, in most organs we found
ALPP
 cells located in the immediate vicinity to blood vessels
(Fig. 2I), staining negative for tomato lectin or CD34, as shown
here for liver. We hypothesized that these cells might represent
pericytes. In order to answer the question whether EC in lymph
capillaries were ALPP
, we tried to specifically stain lymph ves-
sels by using an antibody specific to lymphatic vessel endothelial
hyaluronan receptor-1. However, specific immunostaining of
lymph vessels failed in our ethanol-fixed tissue samples (data not
shown). Similarly, anti-human vWF staining did not work reliably
in our ethanol-fixed paraffin sections (data not shown).
In order to unequivocally document the nature of the ALPP-
expressing endothelial- and pericyte-like cells, we developed a
pre-embedding anti-ALPP immunostaining method for electron
microscopic analysis. Similar to paraffin histology, semi-thin sec-
tions of epon-embedded thick kidney cryosections stained with
anti-ALPP antibody by a pre-embedding protocol suggested that
the BM-derived ALPP
 cells represent capillary EC situated
between the renal tubuli (Fig. 2J, K). Figure 2L and M shows a rep-
resentative ultra-thin section of the immunostained heart with the
appropriate negative controls (Fig. 2N, O). The capillary EC shown
in Figure 2L and at higher magnification in Figure 2M stained
clearly positive for the marker enzyme, whereas staining was
absent in the negative controls. In heart and kidney, we found no
evidence for ALPP-labelled pericytes or ALPP-labelled EC in lymph
capillaries by immuno-electron microscopy.
Two other observations made in this experiment are notewor-
thy. First, the number of labelled capillary EC increased with time
after transplantation in all analysed tissues, as demonstrated for
heart muscle in Figure 2D–F. Under the assumption of a steady
state the increase in labelling index should follow a one-phase
exponential model [18]. Nonlinear regression analysis of the
increase in labelling index over time revealed a half time of 8.36 weeks
(Fig. 2P), and a plateau of 24  14%. These findings suggest that
about a fourth of the total capillary EC in the heart are BM derived,
and that this myocardial EC compartment undergoes rapid
turnover. Second, in the kidney, BM-derived regeneration of EC
was not uniform, but followed a distinct pattern: Replacement was
most intense in the cortical regions (Fig. 2Q), in the glomerula
(Fig. 2Q), and in the vasa recta of the renal papilla (Fig. 2S), but
low in the medullary regions (Fig. 2R).
Epithelial cells in BMT rats are host-derived
While epithelial cells show strong ALPP expression in ALPP-tg rats
(Fig. 1A–C, F–G), we never observed a single ALPP
 epithelial cell
at any time-point in gut (Fig. 3A), kidney (Fig. 3B), liver (Fig. 3C),
skin (Fig. 3D), brain (not shown), lung (Fig. 3E) or pancreas 
(Fig. 3F–H) in our BMT rat model. The ALPP
 cells in these tissues
were EC, leucocytes, and some glial cells in the brain (data not
shown). The number of ALPP-labelled Kupffer cells in the liver (data
not shown) and of alveolar macrophages (Fig. 3E) in the lung dis-
tinctly increased with time after BMT, showing that there is a high
turnover of these tissue-specific macrophages in liver and lung.
However, ALPP
– CD68
 alveolar macrophages could be found even
4 months after BMT, suggesting that some of these cells have a
lifespan exceeding 4 months in the adult rat, even after irradiation
(Fig. 3E). Figure 3F to H shows that ALPP
 cells found in islets of
Langerhans did not stain positive for insulin (F), somatostatin (G) or
pancreatic polypeptide (H), 6 months after BMT.
Lack of BM-derived mesenchymal cells in BMT rats
Osteoblasts, osteocytes and chondrocytes were exclusively ALPP
–
in bones of BMT rats until the end of study, i.e. 6 months after
BMT (Fig 4A–C). Histochemical staining of blood vessels (Fig. 4D)
and skeletal muscle (Fig. 4E) did not provide evidence for BM-
derived, ALPP
 smooth muscle cells or muscle fibres. Similarly,
when we examined smooth muscle cells in the intestine, only
extremely few ALPP
 cells stained also positive for SMA (Fig. 4F).
Most ALPP
 cells were located between SMA-stained smooth
muscle cells, and likely represent EC (Fig. 4G).
All cardiomyocytes in BMT animals were ALPP
– throughout the
study. However, we found a substantial number of ALPP
 cells near
the insertion of the heart valves and in the valvular leaflets (Fig. 4H).
Some of these ALPP
 cells stained positive for vimentin (Fig. 4I),
and some also for SMA (data not shown), suggesting differentiation
of BM-derived cells into cardiac fibroblasts or myofibroblasts. In
addition, we observed numerous vimentin
 but ALPP
– cardiomy-
ocyte-like cells (Fig. 4J), also in regions of valvular insertions. In the
remaining heart muscle vimentin
 and ALPP
– cardiomyocytes-like
cells were rarely seen (Fig. 4K). These vimentin-expressing car-
diomyocyte-like cells might represent early differentiated cardiomy-
ocytes, situated especially at sites of peak mechanical stress such
as at the valvular insertion sites. In rare cases, we found SMA and
vimentin double positive cardiomyocytes (Fig. 4L). Interestingly, we
found several clusters of ALPP
–, vimentin
 cells in epicardial areas
of the heart basis (Fig. 4M) which may represent a pool of undiffer-
entiated endogenous cardiac-resident stem cells.J. Cell. Mol. Med. Vol 15, No 10, 2011
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Mesenchymal precursor cells do not engraft 
in BMT rats
The failure to detect any ALPP
, BM-derived mesenchymal 
lineage cells in bone or striated and smooth muscle of BMT rats
irrespective of the time after BMT prompted us to ask the question
whether stromal precursor cells engraft after BMT with unfraction-
ated BM. To answer this question, we isolated and cultivated MSC
from BM of wt, ALPP-tg and BMT rats, 4 weeks after BMT. In line
with our earlier report [13], MSC from ALPP-tg animals showed
strong expression of ALPP as revealed by histochemistry (Fig.
5C). MSC cultivated from the BM of wt (Fig. 5A) and also of BMT
(Fig. 5B) rats did not show positive ALPP staining. To rule out a
down-regulation of marker enzyme expression in ALPP-tg cells in
a wt environment, we performed Southern blot analysis of DNA
extracted from the MSC cultures. Southern blot analysis clearly
documented the absence of the ALPP transgene in MSC cultures
of BMT rats. These findings indicate that mesenchymal precursor
cells do not engraft after lethal irradiation of wt rats and reconsti-
tution with unfractionated BM from ALPP-tg donor rats.
Discussion
The goal of the current study was to monitor the renewal of
peripheral tissues by BM-derived cells in adult rats, using a
marker protein which can readily be detected in semi-thin paraf-
fin and plastic sections by histochemistry or IHC, and in ultrathin
sections by transmission electron microscopy after pre-embed-
ding immunostaining. In analogy to a plethora of similarly
designed earlier studies using fluorescent proteins or LacZ as
genetic markers of BM-derived cells, our study was undertaken
under the premise that lethal irradiation and reconstitution with
unfractionated BM would result in engraftment of mesenchymal
precursor cells in the recipient. However, we found that this
premise is wrong, at least in rats. Therefore, we could only exam-
ine cellular turnover originating from the haematopoietic BM
compartment. Our data show that the haematopoietic BM com-
partment is an important source of EC renewal in capillaries of
many, but not all organs. However, haematopoietic BMC do not
contribute to physiological regeneration of muscle, bone, carti-
lage or epithelial tissues.
The role of BM in EC turnover is a controversial issue. While
it was reported that BM-derived cells contribute to blood and 
lymphatic capillary endothelium [19], and to neovascularization
in wound healing [20] or in scar remodelling after myocardial
infarction [21], other authors failed to find BM-derived EC in
mouse models of tumour vascularization or revascularization of
ischemic tissue [22, 23]. Some mouse studies suggested that
BM-derived cells in blood vessels represent pericytes [22, 23].
Using immuno-electron microscopy, we found no evidence of
BM-derived pericytes or lymphatic EC in heart and kidney. Rather,
with the exception of circulating blood cells all ALPP-labelled
cells were unequivocally capillary EC in blood vessels of heart and
kidney. It is currently unclear whether the discrepancies between
some mouse and our rat study could be explained by species 
differences in BM-derived EC turnover.
Interestingly, we observed organ-specific turnover patterns of
capillary EC in our study. Replacement of capillary EC by BM-
derived cells was highest in heart and kidney. Low turnover was
seen in brain and adrenal medulla. In accordance with our find-
ings, studies in mice transplanted with lacZ-expressing BM
reported low values for physiological replacement of EC by BM-
derived precursors in skin and brain [24]. In most organs, the
number of ALPP-labelled EC increased with time, and, with the
exception of kidney, showed a homogenous distribution pattern.
The reason for the regional differences in renal BM-derived EC
turnover is currently unclear. It is known that lethal irradiation
Fig. 2 Light and electron microscopic analysis of tissues from wt F344 rats, lethally irradiated and reconstituted with BM from ALPP-tg F344 donors.
ALPP
 endothelial-like cells in capillaries are evident in kidney (A), pancreas (B) and liver (C), 2 months after BM transplantation (BMT). The number of
ALPP
 endothelial-like cells increased with time in all organs as shown for heart tissue 1 (D), 2 (E) and 4 (F) months after BMT. In contrast, ALPP
 EC
were absent in large blood vessels such as the Aorta thoracica (G), arteries or veins (not shown). (H) Double staining (arrows) for ALPP by histochem-
istry (blue) and for tomato lectin Lycopersicon esculentum (purple) confirmed the endothelial nature of the putative BM-derived capillary EC in the
myocardium, 2 months after BMT. (I) ALPP
 cells in the vicinity of blood vessels as shown here in liver. Semi-thin serial sections of epon-embedded, 45-
m-thick kidney cryosections stained immunohistochemically against ALPP by a pre-embedding protocol and counterstained with toluidine blue (J) or
left without counterstaining (K, brown DAB immunoprecipitate) show that the anti-ALPP staining (arrows in K) co-localized with capillaries situated
between renal tubuli (arrows in J), 6 months after BMT. (L)–(O) Transmission electron microscopy (TEM) of ultra-thin sections of the heart muscle after
pre-embedding anti-ALPP staining clearly showed that the BM-derived ALPP
 endothelial-like cells are indeed capillary EC, 6 months after BMT. Higher
magnification is shown in (M). Anti-ALPP staining was absent in control sections of hearts from BMT rats when the primary antibody was omitted (N) or
in wt controls (O). (P) Nonlinear regression analysis of the time dependent increase in BM-derived EC in the heart muscle revealed a half time of 8.36
weeks for these cells. (Q)–(S) In the kidney, EC turnover showed marked inhomogeneity. BM-derived ALPP
 EC were more frequent in cortical regions
(Q) and in the Vasa recta of the papilla (S) than in medullary areas (R) throughout the study period, as demonstrated here at 2 months after BMT. The 5-
m-thick paraffin sections shown in (A)–(G), (I) and (Q)–(S) were stained for ALPP enzyme activity with BCIP/NBT (purple) overnight at RT after heat
pre-treatment, and were counterstained with nuclear fast red. Semi-thin and ultra-thin sections shown in (J)–(O) were immunostained using a mono-
clonal anti-ALPP antibody by the pre-embedding protocol described in ‘Methods’. Bars represent 50 m for light microscopy and 2.5 m for transmis-
sion electron microscopy.J. Cell. Mol. Med. Vol 15, No 10, 2011
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damages EC (reviewed in [25]). Therefore, replacement of EC seen
at 4 weeks after transplantation could be due to cell damage
induced by irradiation. However, it is unlikely that radiation-
induced cell damage can explain the increase in labelled EC at the
later time-points.
In the current study, we calculated a half time of 8.36 weeks for
BM-derived EC replacement in cardiac muscle. Using a completely
different methodology, namely assessment of cellular half life by
analysing the decline in labelling index after long-term 5-bromo-
2-deoxyuridine (BrdU) labelling in non-irradiated rats, we
reported a cardiac capillary EC half life of 2.2 weeks [18]. Although
both methods are not directly comparable because different cellu-
lar compartments might be assessed (BrdU labels proliferating
cells irrespective of their origin), they nevertheless show that there
Fig. 3 Lack of BM-derived ALPP

epithelial cells in irradiated wt F344 rats
reconstituted with unfractionated BM
from ALPP-tg F344 donors.
Histochemical detection of ALPP
enzyme activity (BCIP/NBT, purple)
reveals absence of BM-derived epithelial
cells in gut (A), kidney tubules (B), liver
(C), or skin (D), 6 months after BMT. (E)
Co-staining of ALPP enzyme activity
(blue) and anti-CD68 antibody (purple) in
lung sections shows many double posi-




as indicated by arrows, 4 months after
BMT. Double staining of ALPP enzyme
activity (blue) with anti-insulin (F), anti-
somatostatin (G) or anti-pancreatic
polypeptide (H) (purple) demonstrates
lack of BM-derived endocrine cells in
islets of Langerhans. The paraffin sec-
tions shown in (A–D) were stained for
ALPP enzyme activity with BCIP/NBT
(purple) overnight at RT after heat pre-
treatment, and were counterstained with
nuclear fast red. The paraffin sections in
(E–H) were stained for ALPP enzyme
activity using Vector Blue, and
immunostained against CD68, insulin,
somatostatin, or pancreatic polypeptide
using Vector VIP (purple) as substrate.
Bars represent 50 m.2240 © 2011 The Authors
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Fig. 4 Renewal of mesenchymal cells in irradiated wt F344 rats reconstituted with unfractionated BM from ALPP-tg F344 donors, 4–6 months after BMT.
Sections of methylmethacrylate-embedded bones from reconstituted wt F344 rats do not show evidence of ALPP
 BM-derived osteoblasts (A, arrows),
osteocytes (B, arrows), bone lining cells (B, arrowhead) or chondrocytes (C). In contrast, BMC were strongly positive for the marker enzyme (A, B).
Histochemical detection of the marker enzyme in paraffin sections shows absence of BM-derived smooth muscle cells in aorta (D), and absence of ALPP-
expressing muscle fibres in skeletal muscle (E). Cells staining double positive (arrowhead) for ALPP activity (blue) and anti- SMA (purple) were rarely
present in the gut (F). In contrast, BM-derived single ALPP
 endothelial-like cells (blue) located between the smooth muscle cells could be frequently
found (G, arrows). In the heart, we found numerous ALPP
 cells nearby valvular insertion sites and in the valvular leaflets, here at 4 months after BMT
(H). Combination of ALPP-staining (blue) with immunohistochemical staining against vimentin (purple) or SMA (not shown) demonstrated that the BM-
derived cells in the valvular insertion areas partially also stained positive for vimentin, suggesting a fibroblast-like nature (I, arrowheads). Numerous sin-
gle vimentin
 cells with cardiomyocyte-like morphology could also be found at the valvular insertion sites, indicated by arrows (J), as well as rarely in
the working myocardium (arrowhead in K), throughout the study period. In rare cases, these vimentin
 (purple) cardiomyocyte-like cells stained also
positive for SMA (blue), possibly reflecting early differentiated cardiomyocytes (L). Moreover, in epicardial areas of the heart base, we found several clus-
ters of vimentin
 ALPP
– cells (M), potentially representing a cardiac resident stem cell pool. The 5-m-thick paraffin and methylmethacrylate sections
shown in (A–E) and (H) were stained for ALPP enzyme activity with BCIP/NBT (purple) overnight at RT after heat pre-treatment, and were counterstained
with nuclear fast red. The paraffin sections in (F–G) and (I–M) were stained for ALPP enzyme activity using Vector Blue, and immunostained against
vimentin or SMA using Vector VIP (purple) or Vector Blue (L) as substrate. Bars represent 50 m.J. Cell. Mol. Med. Vol 15, No 10, 2011
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is a rapid turnover of capillary EC in the heart. However, we
demonstrated that labelled EC were absent in large blood vessels
and in the adrenal medulla throughout the 6-month experimental
period. It remains unclear whether EC turnover does not take place
at these sites or whether the replacement is driven exclusively by
mitosis of local cells. In this context, it is interesting to note that
we never found BrdU
 EC in arterial or venous blood vessels
(unpublished data) in the long-term BrdU-labelling study men-
tioned above [18]. Collectively, these observations suggest that
physiological EC turnover is absent or very low in larger vessels.
Several reports from sex-mismatched BMT in human beings
and from mice reconstituted with GFP or lacZ-labelled BM have
suggested that BM-derived cells participate in cell renewal of
epithelial [4, 8, 9, 26–29] and also mesenchymal cells [30] in var-
ious organs. In our experiment BM-derived cells did not contribute
to epithelial or mesenchymal repair processes. In accordance with
our results, more recent reports in reconstituted mouse models
have suggested that turnover and regeneration of epithelial cells in
the adult endocrine pancreas [31], kidney [10], upper respiratory
tract [32] and lung [12], even after tissue damage, does not
involve BM-derived cells. Technical problems with the histological
detection of the Y-chromosome, or with fluorescent marker pro-
teins such as GFP and non-specific tissue auto-fluorescence
might be the reason for the discrepant findings.
It is still controversial whether stromal cells are engrafted dur-
ing BMT with unfractionated BM. Although some contrasting find-
ings have been reported [33], the majority of studies in patients
after allogeneic BMT reported that BM-derived MSC in these
Fig. 5 MSC culture reveals lack of MSC
engraftment in reconstituted rats.
Histochemical staining after heat pre-
treatment of cultured and fixed MSC iso-
lated from wt F344 rats (A), from lethally
irradiated wt F344 rats reconstituted
with unfractionated BM of ALPP-tg co-
isogeneic donors, 4 weeks after BMT
(BMT,  B), or from ALPP-tg F344 rats
(C). ALPP staining was absent in wt (A)
and BMT MSC (B), whereas MSC of
ALPP-tg donors showed strong ALPP
expression (C). (D) Fixed and stained
MSC in 25 cm
2 culture flasks from top
to bottom: MSC of wt, BMT and ALPP-tg
F344 rats. (E) Southern blot analysis of
DNA isolated from cultured MSC con-
firms the absence of the marker trans-
gene in DNA samples isolated from wt
(left line) and BMT rats (right line), in
contrast to the ALPP-tg donor (middle
line).2242 © 2011 The Authors
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patients are of recipient origin [34–37]. The methods used to
determine the origin of stromal cells in these studies ranged from
demonstration of a Y-chromosome after sex-mismatched BMT
[34, 35, 37] to DNA fingerprinting methods [37]. In accordance
with the clinical reports, our data did neither provide evidence for
ALPP-expressing mesenchymal cells of donor origin in bone or
peripheral tissues of BMT rats irrespective of the time-point after
BMT, nor of ALPP
 MSC after culture of BM harvested from BMT
rats. Along similar lines, Wang et al. [38] showed that in irradiated
mice reconstituted with unfractionated BM of Col1a1-GFP reporter
transgenic mice, GFP-expressing cells did not differentiate into
osteocytes. However, other studies in mice reported donor-
derived chimerism of MSC after irradiation and transplantation of
unfractionated BMC or MSC [39–41]. The reason for the contrast-
ing findings between some mouse experiments and studies in
human beings and rats remains unclear. However, there is evi-
dence that strain-related differences in the sensitivity of murine
MSC to irradiation may be involved [40].
Why do stromal precursors, although certainly present in
unfractionated BM, not engraft in lethally irradiated human beings
and rats? MSC show relative radioresistance in vitro and may not
be affected by the irradiation regimen [42]. Therefore, the most
likely explanation is that, in contrast to haematopoietic stem cells,
a niche for stromal precursor cells is lacking in BM of irradiated
animals. Given the fact that the MSC pool remained recipient-
derived in our study, how can the occurrence of BM-derived
ALPP
 fibroblasts in certain organs such as heart or intestine be
explained? Other investigators have also reported the presence of
BM-derived fibroblasts in kidney, valvular leaflets of the heart or
skin during wound healing after transplantation of unfractionated
BM or even haematopoietic stem cells in mice [43–45]. Moreover,
studies in a mouse model of cardiac fibrosis have provided firm
evidence of a blood-borne, BM-derived fibroblast precursor popu-
lation of haematopoietic origin, giving rise to 	-SMA, type I colla-
gen, CD34 and CD45
 cardiac fibroblasts [46]. Thus, our data
corroborate the existence of a distinct blood-borne population of
fibroblast precursors of haematopoietic origin also in the rat.
In the current study, we found some ALPP
–, vimentin and/or
SMA-staining cardiomyocyte-like cells in the heart, especially in
areas of high mechanical stress. This finding may implicate that,
given the assumption that these vimentin-expressing cells can be
defined as early differentiated cardiomyocytes [47], the heart may
be capable of limited regeneration through differentiation of car-
diac stem cells [48]. However, although these repair mechanisms
may be suitable to compensate physiologic cell death especially
at sites of high mechanical demand, they without doubt fail to
compensate extensive loss of cardiomyocytes after ischemia-
reperfusion injury [21]. We demonstrated that in our model
engraftment of donor-derived MSC did not take place. Therefore,
we cannot rule out a possible recruitment of BM-derived mes-
enchymal precursors in mesenchymal tissue turnover, because
the recipient-derived BM-MSC could not be tracked in our study.
However, a study of heterotopic transplantation of wt rat hearts
into transgenic rats ubiquitously expressing GFP showed that
BM-derived cardiomyocyte turnover represents a negligible event
under more or less physiologic conditions [49].
In conclusion, our study clearly showed that haematopoietic
BMC are an important source of physiological renewal of
endothelial, but not of epithelial or mesenchymal, cells in many
organs of adult rats. Thus, our data corroborate the notion that
the major source of endothelial precursor cells in BM is of
haematopoietic origin [50]. Because mesenchymal precursor
cells did not engraft after BMT with unfractionated BM, our study
questions the usefulness of reconstituted irradiated rats as a
model for evaluating BM-driven regeneration of mesenchymal
cells in peripheral tissues.
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